Market Overview:
The global pharmaceutical CMO services market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for outsourcing of pharmaceutical and biotechnology products by various companies across the globe. Active Pharmaceutical Ingredients (APIs) are expected to dominate the global pharmaceutical CMO services market in terms of revenue, followed by Finished Dose Formulations (FDFs) and Packaging. North America is expected to lead the global pharmaceutical CMO services market in terms of revenue, followed by Europe and Asia Pacific.
Product Definition:
Pharmaceutical CMO Services are outsourced services offered by Contract Manufacturing Organizations (CMOs) to the Pharmaceutical and Biotech industries. Pharmaceutical CMO Services can include manufacturing, formulation development, analytical testing, scale-up and technology transfer. The importance of Pharmaceutical CMO Services lies in their ability to provide cost-effective and high quality products while freeing up internal resources for companies to focus on their core competencies.
Active Pharmaceutical Ingredients (APIs):
APIs are the combination of active ingredients used in pharmaceutical formulations. They are responsible for the therapeutic effect and improvement in drug efficacy. The growth factor for APIs is increasing demand from small molecule drugs to treat chronic diseases such as cancer, diabetes, etc. Due to their cost-effectiveness and high efficiency; they have become an essential part of modern pharmaceuticals that help reduce dosage frequency & adverse effects while maintaining effectiveness & specificity required by doctors or patients.
Finished Dose Formulations (FDFs):
Finished Dose Formulations (FDFs) are the most widely accepted and practiced drug delivery formulations in the pharmaceutical industry. The advantages of FDFs include simple preparation, cost-effectiveness, enhanced bioavailability of active ingredients, improved patient compliance and dosing frequency along with increased therapeutic efficacy is expected to boost market growth over the forecast period.
Application Insights:
The pharmaceutical industry accounted for the largest share of revenue in 2016. The segment is expected to witness significant growth on account of increasing healthcare spending by governments as well as private organizations, growing demand for generic drugs and rising innovation in medicines.
The biotechnology industry is anticipated to grow at a lucrative rate over the forecast period owing to increasing R&D activities pertaining to new drug development and introduction of advanced therapeutics. Increasing investments by companies such as Pfizer, Inc., Merck KGaA, Novo Nordisk A/S., Amgen Inc., sanofi-aventis ULC are expected to propel market growth during the study period.
Increasing government support for research & development (R&D) pertaining innovative products including biosimilars and gene therapies is anticipated drive market growth during the forecast period.
Regional Analysis:
Asia Pacific accounted for the largest revenue share in 2017 and is anticipated to continue its dominance over the forecast period. The region’s growth can be attributed to rising R&D investments by global players, increasing outsourcing activities, and growing healthcare spending. In addition, favorable government policies such as 100% FDI allowed under automatic route are expected to create ample opportunities for CMOs in this region.
The Asia Pacific pharmaceutical CMO services market is expected to grow at a lucrative rate during the forecast period owing to factors such as low manufacturing cost of drugs due to availability of cheap labor & raw materials coupled with high demand from local end-use markets resulting into higher sales volume which eventually leads into lower manufacturing costs per dosage unit.
In terms of revenue generation, Europe was estimated at USD X million in 2017.
Growth Factors:
- Increasing demand for generic drugs: The global pharmaceutical market is expected to grow at a CAGR of 6.5% from 2016 to 2020, owing to the increasing demand for generic drugs and rising prevalence of chronic diseases. This is expected to drive the growth of the pharmaceutical CMO services market during the forecast period.
- Rising R&D expenditure by pharma companies: Pharmaceutical companies are increasingly allocating more funds towards R&D in order to develop new products and therapies. This is expected to result in an increase in outsourcing of R&D services, thereby driving the growth of the pharmaceutical CMO services market during the forecast period.
- Growing focus on contract manufacturing: Contract manufacturing has emerged as a preferred mode of production for many pharma companies due to its benefits such as lower costs and shorter turnaround times. This is anticipated to fuel the growth ofthe pharmaceutical CMO services market duringthe forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharmaceutical CMO Services Market Research Report
By Type
Active Pharmaceutical Ingredients (APIs), Finished Dose Formulations (FDFs), Packaging
By Application
Pharmaceutical Industry, Biotechnology Industry
By Companies
Lonza, Boehringer Ingelheim, FUJIFILM Diosynth Biotechnologies, AGC Chemicals, AbbVie, Pfizer, Evonik Health Care, Delpharm, Recipharm, Teva API, Catalent, Esteve Quimica, Fareva, Patheon, Piramal, Hisun Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
138
Number of Tables & Figures
97
Customization Available
Yes, the report can be customized as per your need.
Global Pharmaceutical CMO Services Market Report Segments:
The global Pharmaceutical CMO Services market is segmented on the basis of:
Types
Active Pharmaceutical Ingredients (APIs), Finished Dose Formulations (FDFs), Packaging
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical Industry, Biotechnology Industry
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Lonza
- Boehringer Ingelheim
- FUJIFILM Diosynth Biotechnologies
- AGC Chemicals
- AbbVie
- Pfizer
- Evonik Health Care
- Delpharm
- Recipharm
- Teva API
- Catalent
- Esteve Quimica
- Fareva
- Patheon
- Piramal
- Hisun Pharmaceuticals
Highlights of The Pharmaceutical CMO Services Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Active Pharmaceutical Ingredients (APIs)
- Finished Dose Formulations (FDFs)
- Packaging
- By Application:
- Pharmaceutical Industry
- Biotechnology Industry
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharmaceutical CMO Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pharmaceutical CMO Services is a business model that provides pharmaceutical companies with marketing and communications services. These services help companies to identify and reach target audiences, create effective marketing campaigns, and manage customer relationships. Pharmaceutical CMO Services also helps companies to understand the latest trends in the pharmaceutical industry so that they can make informed decisions about their marketing strategies.
Some of the major players in the pharmaceutical cmo services market are Lonza, Boehringer Ingelheim, FUJIFILM Diosynth Biotechnologies, AGC Chemicals, AbbVie, Pfizer, Evonik Health Care, Delpharm, Recipharm, Teva API, Catalent, Esteve Quimica, Fareva, Patheon, Piramal, Hisun Pharmaceuticals.
The pharmaceutical cmo services market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pharmaceutical CMO Services Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pharmaceutical CMO Services Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pharmaceutical CMO Services Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pharmaceutical CMO Services Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pharmaceutical CMO Services Market Size & Forecast, 2018-2028
4.5.1 Pharmaceutical CMO Services Market Size and Y-o-Y Growth
4.5.2 Pharmaceutical CMO Services Market Absolute $ Opportunity
Chapter 5 Global Pharmaceutical CMO Services Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pharmaceutical CMO Services Market Size Forecast by Type
5.2.1 Active Pharmaceutical Ingredients (APIs)
5.2.2 Finished Dose Formulations (FDFs)
5.2.3 Packaging
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pharmaceutical CMO Services Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pharmaceutical CMO Services Market Size Forecast by Applications
6.2.1 Pharmaceutical Industry
6.2.2 Biotechnology Industry
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pharmaceutical CMO Services Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pharmaceutical CMO Services Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pharmaceutical CMO Services Analysis and Forecast
9.1 Introduction
9.2 North America Pharmaceutical CMO Services Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pharmaceutical CMO Services Market Size Forecast by Type
9.6.1 Active Pharmaceutical Ingredients (APIs)
9.6.2 Finished Dose Formulations (FDFs)
9.6.3 Packaging
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pharmaceutical CMO Services Market Size Forecast by Applications
9.10.1 Pharmaceutical Industry
9.10.2 Biotechnology Industry
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pharmaceutical CMO Services Analysis and Forecast
10.1 Introduction
10.2 Europe Pharmaceutical CMO Services Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pharmaceutical CMO Services Market Size Forecast by Type
10.6.1 Active Pharmaceutical Ingredients (APIs)
10.6.2 Finished Dose Formulations (FDFs)
10.6.3 Packaging
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pharmaceutical CMO Services Market Size Forecast by Applications
10.10.1 Pharmaceutical Industry
10.10.2 Biotechnology Industry
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pharmaceutical CMO Services Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pharmaceutical CMO Services Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pharmaceutical CMO Services Market Size Forecast by Type
11.6.1 Active Pharmaceutical Ingredients (APIs)
11.6.2 Finished Dose Formulations (FDFs)
11.6.3 Packaging
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pharmaceutical CMO Services Market Size Forecast by Applications
11.10.1 Pharmaceutical Industry
11.10.2 Biotechnology Industry
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pharmaceutical CMO Services Analysis and Forecast
12.1 Introduction
12.2 Latin America Pharmaceutical CMO Services Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pharmaceutical CMO Services Market Size Forecast by Type
12.6.1 Active Pharmaceutical Ingredients (APIs)
12.6.2 Finished Dose Formulations (FDFs)
12.6.3 Packaging
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pharmaceutical CMO Services Market Size Forecast by Applications
12.10.1 Pharmaceutical Industry
12.10.2 Biotechnology Industry
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pharmaceutical CMO Services Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pharmaceutical CMO Services Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pharmaceutical CMO Services Market Size Forecast by Type
13.6.1 Active Pharmaceutical Ingredients (APIs)
13.6.2 Finished Dose Formulations (FDFs)
13.6.3 Packaging
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pharmaceutical CMO Services Market Size Forecast by Applications
13.10.1 Pharmaceutical Industry
13.10.2 Biotechnology Industry
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pharmaceutical CMO Services Market: Competitive Dashboard
14.2 Global Pharmaceutical CMO Services Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Lonza
14.3.2 Boehringer Ingelheim
14.3.3 FUJIFILM Diosynth Biotechnologies
14.3.4 AGC Chemicals
14.3.5 AbbVie
14.3.6 Pfizer
14.3.7 Evonik Health Care
14.3.8 Delpharm
14.3.9 Recipharm
14.3.10 Teva API
14.3.11 Catalent
14.3.12 Esteve Quimica
14.3.13 Fareva
14.3.14 Patheon
14.3.15 Piramal
14.3.16 Hisun Pharmaceuticals
